nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—ABCC8—penis—urinary bladder cancer	0.0805	0.378	CbGeAlD
Glimepiride—CYP2C9—urine—urinary bladder cancer	0.0239	0.112	CbGeAlD
Glimepiride—KCNJ1—renal system—urinary bladder cancer	0.0235	0.11	CbGeAlD
Glimepiride—ABCC8—prostate gland—urinary bladder cancer	0.0192	0.0903	CbGeAlD
Glimepiride—ABCC8—seminal vesicle—urinary bladder cancer	0.0163	0.0764	CbGeAlD
Glimepiride—ABCC8—smooth muscle tissue—urinary bladder cancer	0.0136	0.064	CbGeAlD
Glimepiride—ABCC8—renal system—urinary bladder cancer	0.0131	0.0616	CbGeAlD
Glimepiride—KCNJ11—female reproductive system—urinary bladder cancer	0.0114	0.0535	CbGeAlD
Glimepiride—Glipizide—PPARG—urinary bladder cancer	0.00729	1	CrCbGaD
Glimepiride—KCNJ11—lymph node—urinary bladder cancer	0.00667	0.0313	CbGeAlD
Glimepiride—CYP2C9—female reproductive system—urinary bladder cancer	0.00469	0.022	CbGeAlD
Glimepiride—Somnolence—Gemcitabine—urinary bladder cancer	0.00126	0.00162	CcSEcCtD
Glimepiride—Anorexia—Cisplatin—urinary bladder cancer	0.00126	0.00162	CcSEcCtD
Glimepiride—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00125	0.00161	CcSEcCtD
Glimepiride—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00124	0.00159	CcSEcCtD
Glimepiride—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00124	0.00159	CcSEcCtD
Glimepiride—Somnolence—Fluorouracil—urinary bladder cancer	0.00124	0.00159	CcSEcCtD
Glimepiride—Hypotension—Cisplatin—urinary bladder cancer	0.00124	0.00158	CcSEcCtD
Glimepiride—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00123	0.00158	CcSEcCtD
Glimepiride—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00123	0.00157	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00122	0.00157	CcSEcCtD
Glimepiride—Fatigue—Gemcitabine—urinary bladder cancer	0.00122	0.00157	CcSEcCtD
Glimepiride—Confusional state—Etoposide—urinary bladder cancer	0.00122	0.00157	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00122	0.00156	CcSEcCtD
Glimepiride—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00121	0.00155	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—urinary bladder cancer	0.00121	0.00155	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00121	0.00155	CcSEcCtD
Glimepiride—Asthenia—Thiotepa—urinary bladder cancer	0.00121	0.00155	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.0012	0.00154	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—urinary bladder cancer	0.0012	0.00154	CcSEcCtD
Glimepiride—Influenza—Epirubicin—urinary bladder cancer	0.00119	0.00153	CcSEcCtD
Glimepiride—Pruritus—Thiotepa—urinary bladder cancer	0.00119	0.00153	CcSEcCtD
Glimepiride—Paraesthesia—Cisplatin—urinary bladder cancer	0.00119	0.00152	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00119	0.00152	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—urinary bladder cancer	0.00118	0.00152	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—urinary bladder cancer	0.00118	0.00152	CcSEcCtD
Glimepiride—Dyspnoea—Cisplatin—urinary bladder cancer	0.00118	0.00151	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00117	0.0015	CcSEcCtD
Glimepiride—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00117	0.0015	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00116	0.00149	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—urinary bladder cancer	0.00116	0.00149	CcSEcCtD
Glimepiride—Anorexia—Etoposide—urinary bladder cancer	0.00115	0.00148	CcSEcCtD
Glimepiride—Diarrhoea—Thiotepa—urinary bladder cancer	0.00115	0.00148	CcSEcCtD
Glimepiride—Decreased appetite—Cisplatin—urinary bladder cancer	0.00115	0.00147	CcSEcCtD
Glimepiride—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00115	0.00147	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00114	0.00146	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—urinary bladder cancer	0.00114	0.00146	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—urinary bladder cancer	0.00113	0.00145	CcSEcCtD
Glimepiride—Hypotension—Etoposide—urinary bladder cancer	0.00113	0.00145	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00113	0.00145	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00113	0.00145	CcSEcCtD
Glimepiride—Dizziness—Thiotepa—urinary bladder cancer	0.00112	0.00143	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00111	0.00143	CcSEcCtD
Glimepiride—Urticaria—Fluorouracil—urinary bladder cancer	0.00111	0.00142	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—urinary bladder cancer	0.0011	0.00142	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—urinary bladder cancer	0.0011	0.00141	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00109	0.0014	CcSEcCtD
Glimepiride—Sweating—Methotrexate—urinary bladder cancer	0.00109	0.0014	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00109	0.0014	CcSEcCtD
Glimepiride—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00109	0.0014	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—urinary bladder cancer	0.00109	0.00139	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—urinary bladder cancer	0.00109	0.00139	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—urinary bladder cancer	0.00108	0.00138	CcSEcCtD
Glimepiride—Somnolence—Etoposide—urinary bladder cancer	0.00108	0.00138	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00108	0.00138	CcSEcCtD
Glimepiride—Vomiting—Thiotepa—urinary bladder cancer	0.00107	0.00137	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—urinary bladder cancer	0.00106	0.00137	CcSEcCtD
Glimepiride—Rash—Thiotepa—urinary bladder cancer	0.00106	0.00136	CcSEcCtD
Glimepiride—Dermatitis—Thiotepa—urinary bladder cancer	0.00106	0.00136	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00106	0.00136	CcSEcCtD
Glimepiride—Headache—Thiotepa—urinary bladder cancer	0.00106	0.00135	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00106	0.00135	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—urinary bladder cancer	0.00105	0.00135	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00105	0.00135	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00105	0.00134	CcSEcCtD
Glimepiride—Fatigue—Etoposide—urinary bladder cancer	0.00104	0.00134	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—urinary bladder cancer	0.00104	0.00133	CcSEcCtD
Glimepiride—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00103	0.00132	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—urinary bladder cancer	0.00102	0.00131	CcSEcCtD
Glimepiride—Sweating—Epirubicin—urinary bladder cancer	0.00102	0.00131	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00102	0.00131	CcSEcCtD
Glimepiride—Asthenia—Gemcitabine—urinary bladder cancer	0.00102	0.00131	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00101	0.00129	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—urinary bladder cancer	0.00101	0.00129	CcSEcCtD
Glimepiride—Pruritus—Gemcitabine—urinary bladder cancer	0.001	0.00129	CcSEcCtD
Glimepiride—Nausea—Thiotepa—urinary bladder cancer	0.001	0.00128	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—urinary bladder cancer	0.000998	0.00128	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000994	0.00127	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000991	0.00127	CcSEcCtD
Glimepiride—Pruritus—Fluorouracil—urinary bladder cancer	0.000987	0.00127	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—urinary bladder cancer	0.000985	0.00126	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—urinary bladder cancer	0.000984	0.00126	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000977	0.00125	CcSEcCtD
Glimepiride—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000974	0.00125	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—urinary bladder cancer	0.000973	0.00125	CcSEcCtD
Glimepiride—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000971	0.00124	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000966	0.00124	CcSEcCtD
Glimepiride—Urticaria—Etoposide—urinary bladder cancer	0.000962	0.00123	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—urinary bladder cancer	0.00096	0.00123	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—urinary bladder cancer	0.000958	0.00123	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—urinary bladder cancer	0.000956	0.00123	CcSEcCtD
Glimepiride—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000954	0.00122	CcSEcCtD
Glimepiride—Asthenia—Cisplatin—urinary bladder cancer	0.000949	0.00122	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—urinary bladder cancer	0.000944	0.00121	CcSEcCtD
Glimepiride—Dizziness—Fluorouracil—urinary bladder cancer	0.000922	0.00118	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—urinary bladder cancer	0.000921	0.00118	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000919	0.00118	CcSEcCtD
Glimepiride—Diarrhoea—Cisplatin—urinary bladder cancer	0.000905	0.00116	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000904	0.00116	CcSEcCtD
Glimepiride—Vomiting—Gemcitabine—urinary bladder cancer	0.000902	0.00116	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—urinary bladder cancer	0.0009	0.00115	CcSEcCtD
Glimepiride—Rash—Gemcitabine—urinary bladder cancer	0.000894	0.00115	CcSEcCtD
Glimepiride—Dermatitis—Gemcitabine—urinary bladder cancer	0.000894	0.00115	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—urinary bladder cancer	0.000892	0.00114	CcSEcCtD
Glimepiride—Erythema—Methotrexate—urinary bladder cancer	0.000889	0.00114	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—urinary bladder cancer	0.000889	0.00114	CcSEcCtD
Glimepiride—Headache—Gemcitabine—urinary bladder cancer	0.000889	0.00114	CcSEcCtD
Glimepiride—Vomiting—Fluorouracil—urinary bladder cancer	0.000887	0.00114	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—urinary bladder cancer	0.000884	0.00113	CcSEcCtD
Glimepiride—Rash—Fluorouracil—urinary bladder cancer	0.000879	0.00113	CcSEcCtD
Glimepiride—Dermatitis—Fluorouracil—urinary bladder cancer	0.000879	0.00113	CcSEcCtD
Glimepiride—Headache—Fluorouracil—urinary bladder cancer	0.000874	0.00112	CcSEcCtD
Glimepiride—Asthenia—Etoposide—urinary bladder cancer	0.000869	0.00111	CcSEcCtD
Glimepiride—Pruritus—Etoposide—urinary bladder cancer	0.000857	0.0011	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—urinary bladder cancer	0.000854	0.00109	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—urinary bladder cancer	0.000852	0.00109	CcSEcCtD
Glimepiride—Nausea—Gemcitabine—urinary bladder cancer	0.000843	0.00108	CcSEcCtD
Glimepiride—Vomiting—Cisplatin—urinary bladder cancer	0.000841	0.00108	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—urinary bladder cancer	0.000838	0.00107	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000836	0.00107	CcSEcCtD
Glimepiride—Rash—Cisplatin—urinary bladder cancer	0.000834	0.00107	CcSEcCtD
Glimepiride—Dermatitis—Cisplatin—urinary bladder cancer	0.000833	0.00107	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—urinary bladder cancer	0.000832	0.00107	CcSEcCtD
Glimepiride—Erythema—Epirubicin—urinary bladder cancer	0.000832	0.00107	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—urinary bladder cancer	0.000829	0.00106	CcSEcCtD
Glimepiride—Nausea—Fluorouracil—urinary bladder cancer	0.000828	0.00106	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—urinary bladder cancer	0.000822	0.00105	CcSEcCtD
Glimepiride—Tension—Epirubicin—urinary bladder cancer	0.000816	0.00105	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—urinary bladder cancer	0.000808	0.00104	CcSEcCtD
Glimepiride—Dizziness—Etoposide—urinary bladder cancer	0.000801	0.00103	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—urinary bladder cancer	0.000796	0.00102	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00079	0.00101	CcSEcCtD
Glimepiride—Nausea—Cisplatin—urinary bladder cancer	0.000785	0.00101	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—urinary bladder cancer	0.000784	0.00101	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—urinary bladder cancer	0.00077	0.000988	CcSEcCtD
Glimepiride—Vomiting—Etoposide—urinary bladder cancer	0.00077	0.000988	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—urinary bladder cancer	0.00077	0.000987	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—urinary bladder cancer	0.00077	0.000987	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—urinary bladder cancer	0.000769	0.000986	CcSEcCtD
Glimepiride—Agitation—Epirubicin—urinary bladder cancer	0.000765	0.00098	CcSEcCtD
Glimepiride—Rash—Etoposide—urinary bladder cancer	0.000764	0.000979	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—urinary bladder cancer	0.000763	0.000979	CcSEcCtD
Glimepiride—Headache—Etoposide—urinary bladder cancer	0.000759	0.000973	CcSEcCtD
Glimepiride—Tension—Doxorubicin—urinary bladder cancer	0.000755	0.000969	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—urinary bladder cancer	0.000748	0.000959	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—urinary bladder cancer	0.000745	0.000955	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—urinary bladder cancer	0.000735	0.000943	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—urinary bladder cancer	0.000732	0.000938	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000731	0.000938	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000726	0.00093	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—urinary bladder cancer	0.000725	0.00093	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—urinary bladder cancer	0.000721	0.000924	CcSEcCtD
Glimepiride—Nausea—Etoposide—urinary bladder cancer	0.000719	0.000923	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—urinary bladder cancer	0.000718	0.000921	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—urinary bladder cancer	0.000711	0.000912	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00071	0.000911	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—urinary bladder cancer	0.000707	0.000907	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—urinary bladder cancer	0.000706	0.000905	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000701	0.000899	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—urinary bladder cancer	0.000693	0.000888	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—urinary bladder cancer	0.000692	0.000887	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—urinary bladder cancer	0.000689	0.000884	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—urinary bladder cancer	0.000685	0.000878	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—urinary bladder cancer	0.00068	0.000872	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000679	0.000871	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—urinary bladder cancer	0.000678	0.000869	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000677	0.000868	CcSEcCtD
Glimepiride—Shock—Epirubicin—urinary bladder cancer	0.000668	0.000857	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—urinary bladder cancer	0.000667	0.000855	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000665	0.000853	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—urinary bladder cancer	0.000665	0.000852	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—urinary bladder cancer	0.000663	0.00085	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000656	0.000842	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—urinary bladder cancer	0.000656	0.000842	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—urinary bladder cancer	0.000653	0.000838	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—urinary bladder cancer	0.000652	0.000836	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—urinary bladder cancer	0.000647	0.00083	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—urinary bladder cancer	0.000647	0.00083	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—urinary bladder cancer	0.000645	0.000827	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—urinary bladder cancer	0.000641	0.000822	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—urinary bladder cancer	0.000639	0.000819	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—urinary bladder cancer	0.000634	0.000814	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—urinary bladder cancer	0.000633	0.000812	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—urinary bladder cancer	0.000631	0.000809	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000628	0.000806	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000626	0.000803	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—urinary bladder cancer	0.000626	0.000802	CcSEcCtD
Glimepiride—Shock—Doxorubicin—urinary bladder cancer	0.000618	0.000793	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000615	0.000789	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—urinary bladder cancer	0.000614	0.000788	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—urinary bladder cancer	0.000613	0.000786	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—urinary bladder cancer	0.00061	0.000782	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000607	0.000779	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—urinary bladder cancer	0.000605	0.000776	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—urinary bladder cancer	0.000604	0.000774	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—urinary bladder cancer	0.000599	0.000768	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000598	0.000767	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—urinary bladder cancer	0.000598	0.000766	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000593	0.000761	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—urinary bladder cancer	0.00059	0.000757	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—urinary bladder cancer	0.000587	0.000753	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000586	0.000752	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—urinary bladder cancer	0.000585	0.000751	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—urinary bladder cancer	0.000576	0.000739	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—urinary bladder cancer	0.000574	0.000736	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—urinary bladder cancer	0.000568	0.000729	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000564	0.000723	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00056	0.000718	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00056	0.000718	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—urinary bladder cancer	0.000559	0.000716	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000555	0.000712	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000553	0.000709	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000546	0.0007	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000542	0.000696	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—urinary bladder cancer	0.000542	0.000695	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—urinary bladder cancer	0.000539	0.000692	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—urinary bladder cancer	0.000537	0.000688	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000535	0.000686	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—urinary bladder cancer	0.000521	0.000668	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000518	0.000664	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000514	0.000659	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—urinary bladder cancer	0.000513	0.000658	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—urinary bladder cancer	0.0005	0.000642	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—urinary bladder cancer	0.000499	0.00064	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000497	0.000637	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—urinary bladder cancer	0.000496	0.000637	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—urinary bladder cancer	0.000487	0.000625	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—urinary bladder cancer	0.00048	0.000616	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—urinary bladder cancer	0.00048	0.000615	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—urinary bladder cancer	0.000465	0.000596	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000463	0.000594	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—urinary bladder cancer	0.000461	0.000592	CcSEcCtD
Glimepiride—Rash—Methotrexate—urinary bladder cancer	0.000457	0.000587	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—urinary bladder cancer	0.000457	0.000586	CcSEcCtD
Glimepiride—Headache—Methotrexate—urinary bladder cancer	0.000455	0.000583	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—urinary bladder cancer	0.000451	0.000578	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—urinary bladder cancer	0.000449	0.000576	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—urinary bladder cancer	0.000444	0.00057	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—urinary bladder cancer	0.000432	0.000554	CcSEcCtD
Glimepiride—Nausea—Methotrexate—urinary bladder cancer	0.000431	0.000553	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00043	0.000551	CcSEcCtD
Glimepiride—Rash—Epirubicin—urinary bladder cancer	0.000428	0.000549	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—urinary bladder cancer	0.000428	0.000549	CcSEcCtD
Glimepiride—Headache—Epirubicin—urinary bladder cancer	0.000425	0.000545	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—urinary bladder cancer	0.000415	0.000533	CcSEcCtD
Glimepiride—Nausea—Epirubicin—urinary bladder cancer	0.000403	0.000517	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—urinary bladder cancer	0.000399	0.000512	CcSEcCtD
Glimepiride—Rash—Doxorubicin—urinary bladder cancer	0.000396	0.000508	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—urinary bladder cancer	0.000396	0.000508	CcSEcCtD
Glimepiride—Headache—Doxorubicin—urinary bladder cancer	0.000394	0.000505	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—urinary bladder cancer	0.000373	0.000479	CcSEcCtD
